24 Sep Our Member’s Top Potential Trade Opportunities for September 19, 2016 – September 23, 2016
NASDAQ / NYSE / AMEX CLCD - we posted positive news about its Phase 3 drug study as soon as it hit at 7:48 am on Tuesday morning, September 6th, at $14.11/share. CLCD gapped up huge from the news all the way to $19.50/share then...